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In this study, we investigated interactions among microglia (MG), bone marrow
mesenchymal stem cells (BMSCs) and neurons in cerebral ischemia and the potential
mechanisms using an in vitro oxygen-glucose deprivation (OGD) model. Rat BMSCs
were incubated with conditioned medium (CM) from in vitro cultures of OGD-activated
rat MG and murine BV2 MG cells. Effects of glial cell-derived neurotrophic factor
(GDNF) on rat neuron viability, apoptosis, lactate dehydrogenase (LDH) leakage and
mitochondrial membrane potential (MMP) were analyzed in this model. OGD-activated
MG promoted GDNF production by BMSCs (P < 0.01). Tumor necrosis factor-α
(TNFα), but not interleukin-6 (IL6) or interleukin 1β (IL1β), promoted GDNF production
by BMSCs (P < 0.001). GDNF or CM pre-treated BMSCs elevated neuronal viability
and suppressed apoptosis (P < 0.05 or P < 0.01); these effects were inhibited by the
RET antibody. GDNF activated MEK/ERK and phosphoinositide-3-kinase (PI3K)/AKT
signaling but not JNK/c-JUN. Furthermore, GDNF upregulated B cell lymphoma 2
(BCL2) and heat shock 60 kDa protein 1 (HSP60) levels, suppressed LDH leakage,
and promoted MMP. Thus, activated MG produce TNFα to stimulate GDNF production
by BMSCs, which prevents and repairs OGD-induced neuronal injury, possibly via
regulating MEK/ERK and PI3K/AKT signaling. These findings will facilitate the prevention
and treatment of neuronal injury by cerebral ischemia.
Keywords: neuron, bone marrow mesenchymal stem cell, microglia, glial cell-derived neurotrophic factor, tumor
necrosis factor, oxygen-glucose deprivation
Abbreviations: BCL2, B cell lymphoma 2; BMSCs, bone marrow mesenchymal stem cells; CM, conditioned medium;
GDNF, Glial cell-derived neurotrophic factor; HSP60, heat shock 60 kDa protein 1; IL1β, interleukin-1β; IL6, interleukin-6;
LDH, lactate dehydrogenase; MG, microglia; MMP, mitochondrial membrane potential; OGD, oxygen-glucose deprivation;
TNFα, tumor necrosis factor-α.
Frontiers in Cellular Neuroscience | www.frontiersin.org 1 December 2016 | Volume 10 | Article 283
Lv et al. Interaction of MG, BMSCs and Neurons
INTRODUCTION
Cerebral ischemia is a condition caused by insufficient blood flow
to the brain, which deprives the brain of oxygen, glucose and
other essential substrates, and further blocks the normal brain
metabolism (Busl and Greer, 2010). Cerebral ischemia is related
to the pathogenesis of various diseases such as stroke, hypoxic-
ischemic encephalopathy and Alzheimer’s disease (Moroney
et al., 1997; Koistinaho and Koistinaho, 2005; Perlman, 2006).
The lack of biochemical energy associated with cerebral ischemia
induces neuronal injury, which is characterized by accelerated
neuronal necrosis and apoptosis (Perlman, 2006). Elucidation
of the mechanism underlying cerebral ischemia has indicated
several key factors and substances as targets for the treatment of
related diseases (Lim et al., 2011; Yang et al., 2013). However,
cerebral ischemia remains a complex problem that is yet
to be solved.
Bone marrow mesenchymal stem cells (BMSCs), or
mesenchymal stem cells, are isolated from bone marrow
and possess the capacity to differentiate into various cells
types, including osteoblasts, cardiomyocytes, neurons and
astrocytes (Montzka et al., 2009; Nandy et al., 2014). Due to
these characteristics, BMSCs are showing promise in clinical
trials of osteonecrosis and ischemic cardiomyopathy (Hare
et al., 2012; Zhao et al., 2012). In vitro studies also indicate the
anti-inflammatory and anti-immune properties of BMSCs, with
great potential in preventing transplant rejection (Franquesa
et al., 2012). BMSC treatment inhibits tumor necrosis factor-α
(TNFα) production by activated microglia (MG; Kim et al.,
2009). Moreover, BMSCs have been reported to prevent neuron
cell-like apoptosis (Mo et al., 2012).
MG cells are macrophages in the brain that provide support,
nutrition, protection and repair for neurons. These cells are
activated by neurotoxic agents or signals released by injured
neurons, a process that is often accompanied by elevated MG
cells production of TNFα and interleukins, which contribute to
the protection or degeneration of neurons (Eskes et al., 2003;
Suzuki et al., 2004; Floden et al., 2005). The binary effects of MG
on neurons are still under investigation.
Numerous studies have revealed that glial cell-derived
neurotrophic factor (GDNF) exerts neuroprotective functions
during cerebral ischemia (Lu et al., 2005) and neurotoxicity
(Ortiz-Ortiz et al., 2011); thus, GDNF may hold a pivotal position
in the interaction between MG and neurons. This study aimed
to reveal the interactions between MG and BMSCs in protecting
neurons during ischemia injury. MG, BMSCs and hippocampal
neurons were isolated from Wistar rats and cultured in vitro.
MG or the immortalized murine MG cell line BV2 were activated
by oxygen-glucose deprivation (OGD), and the conditioned
medium (CM) was added to BMSCs to promote GDNF
production. The effects of GDNF on OGD-injured neurons
were analyzed in cell viability and apoptosis assays. Potential
mechanisms were investigated by Western blotting, lactate
dehydrogenase (LDH) assays and mitochondrial membrane
potential (MMP) detection. These results will provide an
improved understanding of the mechanisms underlying
neuron protection as well as fundamental information for
the development of strategies to prevent and treat cerebral
ischemia.
MATERIALS AND METHODS
Animals
BMSCs, MG and neurons were isolated from specific
pathogen-free grade Wistar rats (Vital River Laboratories,
Beijing, China). The rats were maintained under laboratory
conditions with free access to standard diet, sterile water and
controlled temperature (24◦C). The rats were anesthetized by
intraperitoneal injection of chloral hydrate (350 mg/kg) and then
euthanized by cervical dislocation for sampling.
All the animal experiments performed in this study were
approved by the Animal Ethics Committee of Southern
Medical University and were conducted in accordance with the
instruction of our institute. No minors, persons with disabilities
or endangered animal species were involved.
Cell Isolation and Culture
BMSCs were isolated from bilateral femurs and tibias of Wistar
rats (aged 4 weeks) based on a previously described method
(Huang et al., 2015). Briefly, both ends of the bones were removed
to expose the marrow cavity, which was washed in serum-free
Dulbecco’s modified Eagle medium (DMEM, Gibco, Carlsbad,
CA, USA) and the fluid was collected. Cells were collected by
centrifugation at 400× g for 10 min, suspended in DMEM
supplemented with 10% fetal bovine serum (FBS) and penicillin-
streptomycin (100 U/mL, Gibco) at a density of 2× 106 cells/mL.
Cells were then cultured at 37◦C in humidified atmosphere under
5% CO2. After 3 days, the non-adherent cells were discarded.
The culture medium was changed every 3 days and the cells were
passaged at approximately 60% confluence.
The immortalized murine MG cell line BV2 (ATCC,
Manassas, VA, USA) was cultured in DMEM supplemented with
10% FBS at a density of 1 × 105 cells/mL, and incubated at 37◦C
in humidified atmosphere under 5% CO2.
MG were isolated from the brain of newborn (within 24 h)
Wistar rats using a previously described method (Hide et al.,
2002). The cerebral cortex was sampled under sterile conditions
and washed in cold phosphate-buffered saline (PBS). The meninx
and blood vessels on the surface were carefully removed, and the
remaining cerebral cortex was then cut into cubes (approximately
1 mm3) in serum-free DMEM before digestion in 0.05% trypsin
(Gibco) for 30 min at 37◦C. The suspension was centrifuged
at 400× g for 10 min after termination of the digestion, and
the cells were resuspended at a density of 1 × 106 cells/mL in
DMEM supplemented with 10% FBS and penicillin-streptomycin
(100 U/mL). The cells were then incubated at 37◦C in a
humidified atmosphere under 5% CO2 and after approximately
2 weeks, the cells were separated into two layers—the lower
astrocytes and the upper putative MG. The cells were digested in
0.05% trypsin and the dishes were gently shaken to resuspend the
MG. The digestion was terminated and MG were isolated from
the cell suspension by centrifugation, and cultured in complete
DMEM at a density of 1× 106 cells/mL.
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Neurons were isolated from the hippocampus of newborn
Wistar rats. Microvessels were carefully removed, and the
hippocampus was then cut into pieces and digested in 0.125%
trypsin for 20 min at 37◦C. The digestion was terminated and the
cells were filtered and seeded at a density of 1 × 105 cells/mL in
DMEM supplemented with 10% FBS and penicillin-streptomycin
(100 U/mL). The cells were incubated at 37◦C in humidified
atmosphere under 5% CO2.
Experimental Design
To analyze GDNF secretion by BMSCs, BV2 and MG cells
were subjected to OGD for 4 h, and the CM was collected
and centrifuged at 300× g for 10 min. BMSCs were seeded
in 96-well plates at a density of 1 × 104 cells/well. After
incubation for 24 h, the medium was replaced entirely with
200 µL CM; BMSCs subjected to this procedure acted as the
BMSC + BV2/MG + OGD group. The CM of BV2/MG without
OGD induction was also collected and added to BMSCs as the
BMSC + BV2/MG group. The BMSC group did not receive
any treatment. After incubation for 24 h, the BMSCs culture
supernatant in each group was collected for determination of the
GDNF concentration. Complete culture medium was used as the
control group.
To analyze GDNF production by BMSCs following treatment
with TNFα, interleukin (IL) 6 or interleukin 1β (IL1β), the levels
of these cytokines in the CM of the activated BV2 and MG
were detected by ELISA (see ‘‘ELISAs’’ Section). In addition,
BMSCs were treated with TNFα (PeproTech, Rocky Hill, NJ,
USA) at final concentrations of 0, 1, 5, 10, 20 or 50 ng/mL, and
interleukin-6 (IL6) or IL1β (PeproTech) to final concentrations
of 0, 1, 5, 10, 50 or 100 ng/mL. The cells were cultured for 24 h,
and the medium was then collected to determine the GDNF
concentration.
For analysis of the effects of GNDF in repairing OGD injury,
neurons were seeded in 96-well plates (1 × 104 cells/well) for
24 h, before the addition of GDNF (500 ng/L, PeproTech), or
replacement of the medium with BMSCs culture supernatant,
GDNF-silenced BMSCs (see ‘‘siRNA Transfection’’ Section), CM
pre-treated BMSCs, or CM pre-treated GDNF-silenced BMSCs
for 24 h after OGD exposure. Additionally, neurons were treated
with TNFα (5 ng/mL), IL6 (5 ng/mL) or IL1β (5 ng/mL,
PeproTech) for 24 h after OGD.
For detection of the protective effects of GDNF against
OGD injury, neurons were seeded into 96-well plates (1 × 104
cells/well) or 6-well plates (1 × 105 cells/well) for 24 h. GDNF
(500 ng/L) and polyclonal anti-RET (2 µg/mL, the GDNF
receptor) antibody (Santa Cruz Biotechnologies, Santa Cruz, CA,
USA) were added to neurons for 24 h before OGD induction.
OGD Induction
The OGD model was used to activate BV2 and MG cells as well
as to injure BMSC and neurons. In brief, the OGD model was
established by exposure of cells cultured in glucose-free medium
and to a humidified atmosphere of 95% N2 and 5% CO2 at
37◦C for 4 h (Zhou X. et al., 2014). Cells cultured under normal
condition were used as a control group.
siRNA Transfection
For RNA silencing, 150 nmol/L GDNF siRNA (Santa
Cruz Biotechnologies) were transfected into BMSCs using
Lipofectamine 3000 reagent (Invitrogen) following the
manufacturer’s protocol. After 48 h, cells were collected for
use in subsequent experiments.
ELISAs
GDNF concentrations in culture supernatants were determined
using the rat GDNF ELISA Kit (Cusabio, Wuhan, China)
according to the manufacturer’s instructions. Briefly, the
culture supernatant was collected by centrifugation at 300× g for
15 min, and 100µL was added to each well of 96-well plates. After
incubation for 2 h at 37◦C, the supernatant was removed and the
plates were incubated sequentially with the biotin- conjugated
primary detection antibody followed by the horseradish
peroxidase (HRP)-conjugated secondary antibody for 1 h at
37◦C; plates were washed three times between steps. After
addition of the chromogenic substrate, the plates were incubated
in the dark for 30 min at 37◦C. After the reaction was stopped,
optical density (OD) was immediately detected at 450 nm
using the iMark microplate reader (Bio-Rad, Hercules, CA,
USA). Concentrations of TNFα, IL6 and IL1β in BV2 and MG
culture supernatants were also detected using the corresponding
ELISA kit from PeproTech according to the manufacturer’s
instructions.
Cell Viability
Neuron cell viability was evaluated after treatment using the
MTT Cell Proliferation Assay Kit (ATCC) according to the
manufacturer’s instruction. Briefly, neurons (1 × 104 cells) were
seeded in each well of 96-well plates for adherence, and treated
for 24 h. MTT Reagent was added and the plates were incubated
for 4 h before addition of 100 µL Detergent Reagent to dissolve
the purple precipitate. The plates were then incubated in the dark
at room temperature for 2 h, and the OD was detected at 570 nm
using the iMark microplate reader (Bio-Rad).
FIGURE 1 | Conditioned medium (CM) from cultures of oxygen-glucose
deprivation (OGD) activated BV2 and microglia (MG) stimulates glial
cell-derived neurotrophic factor (GDNF) production by bone marrow
mesenchymal stem cells (BMSCs). (A) BV2 or (B) MG cells were exposed
to OGD for 4 h before the addition of CM to BMSCs. After 24 h, GDNF
concentrations in the BMSC culture supernatants were determined by ELISA.
∗∗P < 0.01. ∗∗∗P < 0.001.
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Cell Apoptosis
Cell apoptosis was investigated by flow cytometry after
fluorescein isothiocyanate (FITC) and propidium iodide (PI)
staining with the Annexin V-FITC Apoptosis Kit (BioVision,
Milpitas, CA, USA) according to the manufacturer’s instruction.
In brief, 1 × 105 were cells resuspended in 500 µL
Binding Buffer for each sample. Annexin V-FITC (5 µL)
and PI (5 µL) were added and the cells were incubated
at room temperature for 5 min in the dark immediately
before flow cytometric analysis (BD Biosciences, San Jose, CA,
USA). FITC-positive and PI-negative cells were considered to
be apoptotic.
LDH Assay
LDH release by neurons was detected using the LDH Cytotoxicity
Detection Kit (Roche, Basel, Switzerland) according to the
manufacturer’s instructions. Neurons (1 × 104 cells/well) were
seeded into 96-well plates. OD was detected at 500 nm by the
iMark microplate reader (Bio-Rad).
MMP Detection
MMP of neurons was detected by Rhodamin 123 (Sigma-
Aldrich) staining. Neurons (1 × 106 cells) were washed twice in
artificial cerebral spinal fluid (ACSF, NaCl 124 mM, KCl 3 mM,
NaHCO3 26 mM, NaH2PO4·2H2O 1.24 mM, MgSO4·7H2O
FIGURE 2 | Tumor necrosis factor-α (TNFα), rather than interleukin-6 (IL6) or interleukin-1β (IL1β), elevates GDNF production by BMSCs. In (A) BV2 and
(B) MG, OGD stimulates TNFα, IL6 and IL1β production. (C) GDNF production by BMSCs is promoted after treatment with TNFα for 24 h. (D) IL6 and (E) IL1β
treatment for 24 h does not significantly change GDNF production by BMSCs. ∗∗∗P < 0.001.
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FIGURE 3 | GDNF repairs OGD-induced neuronal injury. (A) Neuronal viability is promoted by pretreatment with GDNF after OGD, and is inhibited by
GDNF-specific siRNA transfection. (B) TNFα, IL6 or IL1β suppresses neuronal viability. ∗P < 0.05. ∗∗P < 0.01. ∗∗∗P < 0.001.
2 mM, CaCl2 2 mM and glucose 10 mM) before addition of
Rhodamine 123 at a final concentration of 5 µg/mL. The cells
were incubated at 37◦C for 45 min and washed again in ACSF
before the fluorescence intensity was detected by flow cytometry.
Western Blotting
The total protein content of neurons was extracted by
M-PER Mammalian Protein Extraction Reagent (Thermo
Scientific, Carlsbad, CA, USA) according to the manufacturer’s
instruction. Protein samples were separated by sodium dodecyl
sulfate-polyacrylamide gel electrophoresis and transferred to
polyvinylidene fluoride membranes (Roche). The membranes
were blocked in 5% skimmed milk for 2 h at room temperature
and then incubated at 4◦C overnight in rabbit polyclonal
or monoclonal antibodies for the specific detection of B
cell lymphoma 2 (BCL2, ab59348, Abcam, Cambridge, UK),
heat shock 60 kDa protein 1 (HSP60, ab46798), mitogen-
activated protein kinase (MAPK) kinase 1/2 (MAP2K1/2 alias
MEK1/2, ab178876), phospho-MEK1/2 (p-MEK1/2, ab194754),
MAPK3/1 (alias ERK1/2, ab17942), p-ERK1/2 (ab76299),
phosphoinositide-3-kinase (PI3K p85, ab191606), p-PI3K
(ab182651), v-akt murine thymoma (pan-AKT, ab8805), p-AKT
(ab38449), MAPK8/9/10 (alias JNK, ab208035), p-JNK, jun
proto-oncogene (c-JUN, ab32137), p-c-JUN (ab32385) and
FIGURE 4 | GDNF prevents OGD-induced neuronal injury. (A) Neuronal viability is promoted by pretreatment with GDNF before OGD, but is suppressed by
anti-RET antibody treatment. (B) Neuronal apoptosis is reduced by GDNF pretreatment before OGD, but is improved by anti-RET antibody treatment. ∗P < 0.05.
∗∗P < 0.01. ∗∗∗P < 0.001.
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FIGURE 5 | GDNF regulates the mitogen-activated protein kinase
(MAPK) kinase (MEK)/ERK and phosphoinositide-3-kinase (PI3K)/v-akt
murine thymoma viral oncogene homolog (AKT) signaling pathways,
but not the JNK/c-JUN pathway. Actin is used as an internal control.
(A) The phosphorylated forms of MEK1/2, ERK1/2, PI3K and AKT (p-MEK1/2,
p-ERK1/2, p-PI3K and p-AKT) are promoted by GDNF and suppressed by
anti-RET antibody treatment. The phosphorylated forms of JNK and c-JUN
(p-JNK or p-c-JUN) are barely changed by GDNF or anti-RET antibody
treatment. (B) Relative protein levels based on Western blot results. NS, not
significant. ∗P < 0.05. ∗∗P < 0.01. ∗∗∗P < 0.001.
Actin (ab3280) which was used as an internal control. After
washing in PBS, the membranes were incubated with the goat
anti-rabbit IgG (HRP-conjugated, ab7090) secondary antibody
at room temperature for 1 h. Positive signals were developed
by EasyBlot ECL Kit (Sangon Biotech, Shanghai, China) and
analyzed with ImageJ 1.49 (National Institutes of Health,
Bethesda, MD, USA).
Statistical Analysis
Data represent the mean ± standard deviation (SD) of five
independent experiments. Data were analyzed by SPSS 20 (IBM,
New York, NY) using Student’s t test or one-way analysis of
variance (ANOVA) as appropriate. P < 0.05 was considered to
indicate statistical significance.
RESULTS
GDNF Production by BMSCs is Stimulated
by TNFα from MG
GDNF production by BMSC was confirmed by analysis of GDNF
concentrations in the culture supernatants (Figures 1A,B). No
obvious changes in GDNF production were detected when
BMSCs were treated directly with BV2 or MG CM (P > 0.05).
However, treatment with the CM of OGD-activated BV2 or
MG significantly elevated GDNF levels in BMSCs culture
supernatants (P < 0.01). Although BV2 and MG also produced
GDNF after OGD induction, the levels were significantly lower
than that in the BMSC + BV2 + OGD group (P < 0.001). It can
be speculated that OGD-activated BV2 and MG produce factors
that further stimulate GDNF production by BMSCs.
Numerous studies have shown that MG produce TNFα,
IL6 and IL1β in response to OGD exposure (Chock and
Giffard, 2005; Zhou et al., 2016); this was also confirmed in
our study. The levels of TNFα, IL6 and IL1β produced by
BV2 and MG were increased by OGD (P< 0.001, Figures 2A,B).
Next, we investigated GDNF concentrations in BMSC culture
supernatants after treatment with TNFα, IL6 or IL1β. Results
showed that BMSCs produced significantly more GDNF after
treatment with TNFα (P < 0.001, Figure 2C). However,
treatment with IL6 and IL1β did not cause an obvious increase
in GDNF production (P > 0.05, Figures 2D,E), suggesting that
TNFα, but not IL6 and IL1β, is secreted by OGD-activated MG,
resulting in the induction of GDNF production by BMSCs.
GDNF Prevents and Repairs OGD-Induced
Neuronal Injury
Next, we performed siRNA-mediated GDNF silencing in
BMSCs to assess the functions of GDNF secreted by BMSCs
on OGD-injured neurons. As shown in Figure 3A, OGD
significantly reduced neuronal viability (P < 0.001). Neurons
cultured with GDNF or BMSCs CM alleviated OGD-induced
suppression of neuronal viability (P < 0.01), while this
effect was partly abolished by GDNF silencing (P < 0.05).
Furthermore, CM pre-treated BMSC exhibited a notable increase
in neuronal viability (P < 0.05), and this increase was also
abolished by GNDF silencing (P < 0.01). These preliminary data
indicate that GNDF produced by BMSCs protects neurons from
OGD-induced damage.
Given that OGD induces the production of TNFα, IL6 and
IL1β by MG, it is possible that these factors in the CM
help to promote neuronal viability via a GDNF-independent
mechanism. Therefore, we treated OGD-injured neurons with
TNFα, IL6 and IL1β to investigate their effects on cell viability. As
shown in Figure 3B, TNFα, IL6 and IL1β treatment diminished
neuronal viability (P < 0.05), indicating the suppressive role of
these pro-inflammatory factors on neuronal viability. Thus, we
inferred neuronal viability was promoted mainly by the increased
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FIGURE 6 | GDNF helps to maintain mitochondrial membrane potential (MMP) and inhibit neuronal injury induced by OGD. (A) Western blot showing
GDNF up-regulates B cell lymphoma 2 (BCL2) and heat shock 60 kDa protein 1 (HSP60) protein levels in neurons after OGD. Actin is used as an internal control.
(B) Relative BCL2 protein level based on Western blot results. (C) Relative HSP60 protein level based on Western blot results. (D) Lactate dehydrogenase (LDH)
assay indicates that GDNF inhibits neuronal LDH leakage after OGD. (E) MMP assay indicates that GDNF helps to maintain neuronal MMP after OGD, but TNFα
decreases MMP. NS, not significant. ∗P < 0.05. ∗∗P < 0.01. ∗∗∗P < 0.001.
GDNF production by BMSCs, rather than by the TNFα, IL6 and
IL1β produced by MG.
Neuronal viability and apoptosis were then investigated
following treatment with GDNF and the anti-RET antibody that
blocks GDNF binding to its receptor before OGD exposure.
GNDF prevented the decrease in neuronal viability and the
increase in the rate of apoptotic cells rate induced by OGD
(P < 0.05 or P < 0.01, Figures 4A,B). More importantly, these
functions of GNDF on neurons were abolished in the presence
of the anti-RET antibody (P < 0.05 or P < 0.01). These data
indicated that GNDF prevents OGD-induced neuronal injury.
GDNF Regulates MEK/ERK, PI3K/AKT and
Mitochondrial Stability in Neurons
Previous research has emphasized the involvement of the
MEK/ERK, PI3K/AKT and JNK/c-JUN signaling pathways in
modulation of cell viability and apoptosis (Oufkir et al., 2010;
Park et al., 2012; Dillon et al., 2015); thus, key components of
these pathways were detected by Western blotting to investigate
the capacity of GDNF to regulate these factors. Results showed
that GDNF elevated the expression of p-MEK1/2, p-ERK1/2,
p-PI3K and p-AKT, and this GDNF-induced elevation was
inhibited in the presence of anti-RET (P < 0.001, Figures 5A,B).
The total level of these proteins was almost unchanged,
suggesting that GDNF promotes their activation. However,
p-JNK and p-c-JUN were induced by OGD but were unaffected
by GDNF or anti-RET (P> 0.05), implying that GDNF regulates
activation of the MEK/ERK and PI3K/AKT pathways but not the
JNK/c-JUN pathway.
To investigate the potential mechanism by which GDNF
attenuates neuronal injury, we also detected the expression of
the apoptosis-related protein BCL2 on mitochondrial membrane
(Gross et al., 1999), and the molecular chaperone HSP60, which
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FIGURE 7 | Schematic diagram of the effects of MG and BMSC on
neurons revealed in this study. Following the stimulation by OGD, MG
secretes TNFα, which further induces BMSCs to produce more GDNF. GDNF
protects neurons against OGD-induced injury. Furthermore, TNFα secreted
from MG induces inflammatory responses to suppress OGD-induced neuronal
injury.
participates in the folding of mitochondrial precursor proteins
(Ostermann et al., 1989). Western blot (Figures 6A–C) analysis
showed that both BCL2 and HSP60 were downregulated after
OGD induction (P < 0.01), and were upregulated by GNDF
administration with or without exposure to OGD conditions
(P < 0.05 or P < 0.01).
LDH assays showed that OGD elevated LDH leakage from
neurons (P< 0.01, Figure 6D). Although GDNF had no obvious
effects on normal neurons (P > 0.05), it markedly decreased
LDH leakage in neurons exposed to OGD (P < 0.01). Thus, it
can be speculated that GDNF helps to maintain the neuronal
membrane integrity after OGD. MMP assays showed similar
changes in that GDNF significantly elevated MMP after OGD
(P < 0.001, Figure 6E). In contrast, TNFα treatment of normal
neurons led to an apparent decrease in MMP (P < 0.01), further
suggesting that the effects mediated by TNFα on neurons are
opposite to those mediated by GDNF. These results indicate
that GDNF maintains mitochondrial stability and suppresses
neuronal injury, thus representing a potential mechanism by
which GDNF protects against OGD-induced neuronal injury.
DISCUSSION
Inspired by existing studies demonstrating the protective
roles of MG and BMSCs on neurons, we constructed an
in vitro OGD model in cultured rat neurons, which were
then treated with CM of BMSCs and OGD-activated MG.
Activated MG produced factors including TNFα, which are
implicated in elevation of GDNF production by BMSCs
and further protecting neurons from OGD-induced injury.
Furthermore, our findings indicate that the mechanism by
GDNF protected neurons from OGD-induced injury is, at
least partially, mediated via activation of the MEK/ERK
and PI3K/AKT signaling pathways and maintenance of
mitochondrial stability.
Analysis of GDNF concentrations in BMSCs culture
supernatants by ELISA indicated significant upregulation of
GDNF after treatment with the CM of OGD-activated MG.
Our results are in accordance with other reports that activated
MG, as well as BMSCs, produce GDNF (García et al., 2004;
Matsushita et al., 2008; Tanaka et al., 2008; Lin et al., 2015).
GDNF production was detected in the culture supernatants of
untreated BMSCs and OGD-induced BV2/MG. However, GDNF
levels were further upregulated when BMSCs were cultured in
the CM of OGD-induced BV2/MG. Thus, it can be deduced
that OGD-induced MG secrete factors that facilitate GDNF
production by BMSCs.
TNFα, IL6 and IL1β are pro-inflammatory factors secreted
by MG activated by stimuli such as OGD (Badiola et al., 2009;
Ziemka-Nałe˛cz et al., 2013). Our results showed that TNFα
(1–50 ng/mL) promoted GDNF production by BMSCs, while
IL6 and IL1β had no significant effects. TNFα exposure has
been found to promote proliferation and invasion by BMSCs
(Miettinen et al., 2011), without affecting pluripotency (Zhang Z.
et al., 2010; Lee et al., 2012), while IL1β and IL6 treatment
inhibits chondrocytic differentiation or maintains the stemness
of BMSCs (Pricola et al., 2009; Ferreira et al., 2013). Thus, we
speculate that the functional disparity between TNFα, IL6 and
IL1β in BMSCs may be related to the differences in the signaling
pathways regulated by these cytokines. The promoting role of
TNFα on GDNF production, as well as the elevated GDNF
production by OGD-induced MG, suggests that TNFα is one of
the factors produced by MG that stimulates GDNF production
by BMSCs.
OGD, which is a common method to construct in vitromodels
for ischemia research, leads to forms of injury including neuronal
necrosis and apoptosis (Pei and Cheung, 2003; Chung et al.,
2007), whereas GDNF exerts a protective effect on neurons,
stimulating viability, proliferation and survival (Saavedra et al.,
2006; Han et al., 2015). In accordance with previous reports,
we demonstrated that OGD decreased neuronal viability and
increased apoptosis, which might reflect neuronal injury caused
by this treatment. Both pre and post-treatment with GDNF
promoted a decrease in neuronal viability and reduced the
number of apoptotic neurons to some extent, suggesting that
GDNF prevents and repairs OGD-induced neuronal injury.
Since GDNF production by BMSCs is further upregulated by
factors such as TNFα, BMSCs may play a pivotal role in
the protection of neurons via the functions of GDNF. We
cannot exclude the possibility that BMSCs are stimulated to
produce factors in addition to GDNF in this process, since
multiple mechanisms have been discovered to be involved in
the protective effects of BMSCs on neurons (Hokari et al.,
2008). However, our results refute the possibility that neuronal
viability is increased by TNFα, IL6 and IL1β produced by
activated MG, because these factors had obvious negative
effects on viability. Elucidation of the precise mechanism
requires further investigation of the altered factors in culture
supernatants.
TNFα exerts both positive and negative influences on
neurons via multiple mechanisms (Saha et al., 2009; Bliss et al.,
2011). This study revealed one of the possible mechanism
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involving the TNFα and GDNF produced by MG and BMSCs,
respectively (Figure 7). Following OGD induction, MG produces
elevated levels of TNFα that influence neurons in two ways.
On the one hand, TNFα suppresses neuron viability directly,
possibly via the anabatic inflammatory responses; on the
other hand, TNFα induces increased GDNF production by
BMSCs to protect neurons. Thus, the protective effects of
GDNF on neurons during ischemia may be one of the
core links in the interaction between neurons, BMSCs and
MG.
Some researchers have detected the inhibitory role of
BMSCs on the production of pro-inflammatory factors
including TNFα and IL1β by activated MG (Jose et al.,
2014; Zhou X. L. et al., 2014). In this study, we investigated
the related mechanism from another perspective regarding
GDNF and three signaling pathways that regulate neuronal
viability and apoptosis. It has been reported that MEK/ERK
pathway has neuroprotective functions in primary cultures
of rat hippocampal neurons (Wang et al., 2013). PI3K/AKT
signaling is necessary for the protection of cortical neurons
(Zhang L. et al., 2010), while activation of JNK/c-JUN signaling
has been detected in the brain neurons in Alzheimer’s
disease models (Akhter et al., 2015). Our results indicate
that GDNF regulates these three signaling pathways in a
discriminatory manner to promote the activation of MEK/ERK
and PI3K/AKT without influencing JNK/c-JUN. Hence,
MEK/ERK and PI3K/AKT signaling are implicated in the
mechanism by which GDNF prevents and repairs neuronal
injury.
In addition to the MEK/ERK and PI3K/AKT signaling
pathways, Western blot analysis showed that GDNF also
regulated BCL2 and HSP60 expression. Based on the
known roles of BCL2 and HSP60 in cell apoptosis and
mitochondrial metabolism, the observed upregulation of
these factors by GDNF suggests that GDNF protects neurons
against OGD-induced injury, possibly by regulating cell
apoptosis. We further demonstrated that GDNF suppressed
LDH leakage and promoted MMP in the OGD model.
Mitochondrial membrane damage and decreased MMP are
considered to be early markers of cell apoptosis (Garedew
and Moncada, 2010), and increased LDH leakage reflects
accelerated cell injury and cell death; thus, these results
indicate that mitochondria-related processes are involved
in the mechanism by which GDNF protects neurons from
OGD-induced injury. Based on research showing that HSP60
up-regulates BCL2 and attenuates cell death (Ghribi et al.,
2001; Shan et al., 2003), we speculate that the detailed
mechanism of this protection involves the regulation of
BCL2 and HSP60 by GDNF, possibly via the mitochondria
apoptosis pathway. However, this hypothesis requires further
verification.
In conclusion, this study indicates that TNFα secreted by
activated MG stimulates BMSCs to produce higher levels of
GDNF, which protects against the OGD-induced neuronal
injury, possibly by regulating the MEK/ERK and PI3K/AKT
signaling pathways. The precise mechanisms involved in the
interaction of neurons, BMSCs and MG require further
investigation to facilitate the development of strategies for
the prevention and treatment of neuron damage by cerebral
ischemia.
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